Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis

49Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Background - It is believed that severe portal hypertensive gastropathy probably accounts for most non-variceal bleeding episodes in patients with cirrhosis. Gastric antral vascular ectasia (GAVE) also occurs in these patients. It is not clear whether it is a variant of portal hypertensive gastropathy or a distinct condition. Patients - A patient, a 66 year old woman, with cirrhosis initially diagnosed as having portal hypertensive gastropathy and subsequently classified as GAVE is described. She required transfusion with a total of 130 units of packed red cells for gastrointestinal blood loss. Results - The bleeding did not respond to portal decompression with TIPS or beta blockers. Following treatment with oral tranexamic acid she has not required further blood transfusion over a period of 30 months. Conclusion -Tranexamic acid may be a useful treatment for refractory bleeding due to gastric antral vascular ectasia in patients with cirrhosis.

Cite

CITATION STYLE

APA

McCormick, P. A., Ooi, H., & Crosbie, O. (1998). Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut, 42(5), 750–752. https://doi.org/10.1136/gut.42.5.750

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free